IP
LGND icon

Isthmus Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.24M Sell
37,273
-402
-1% -$45.7K 0.5% 52
2025
Q1
$3.96M Sell
37,675
-420
-1% -$44.2K 0.5% 49
2024
Q4
$4.08M Sell
38,095
-459
-1% -$49.2K 0.5% 53
2024
Q3
$3.86M Sell
38,554
-9,622
-20% -$963K 0.46% 54
2024
Q2
$4.06M Sell
48,176
-155
-0.3% -$13.1K 0.48% 57
2024
Q1
$3.53M Buy
48,331
+13,984
+41% +$1.02M 0.4% 72
2023
Q4
$2.45M Buy
34,347
+1,530
+5% +$109K 0.32% 72
2023
Q3
$1.97M Buy
32,817
+8,026
+32% +$481K 0.28% 74
2023
Q2
$1.79M Sell
24,791
-103
-0.4% -$7.43K 0.24% 89
2023
Q1
$1.83M Buy
24,894
+5,064
+26% +$373K 0.26% 85
2022
Q4
$1.32M Sell
19,830
-59
-0.3% -$3.94K 0.2% 101
2022
Q3
$1.71M Buy
19,889
+4,209
+27% +$363K 0.29% 74
2022
Q2
$1.4M Buy
15,680
+960
+7% +$85.7K 0.26% 83
2022
Q1
$1.66M Buy
14,720
+1,080
+8% +$122K 0.27% 82
2021
Q4
$2.11M Buy
13,640
+133
+1% +$20.5K 0.35% 64
2021
Q3
$1.88M Buy
13,507
+58
+0.4% +$8.08K 0.34% 63
2021
Q2
$1.76M Buy
13,449
+313
+2% +$41.1K 0.31% 77
2021
Q1
$2M Sell
13,136
-283
-2% -$43.2K 0.37% 59
2020
Q4
$1.34M Buy
13,419
+1,435
+12% +$143K 0.27% 84
2020
Q3
$1.14M Buy
11,984
+1,052
+10% +$100K 0.27% 74
2020
Q2
$1.22M Buy
10,932
+133
+1% +$14.9K 0.3% 64
2020
Q1
$785K Sell
10,799
-649
-6% -$47.2K 0.24% 80
2019
Q4
$1.19M Buy
11,448
+91
+0.8% +$9.49K 0.27% 80
2019
Q3
$1.13M Buy
11,357
+1,581
+16% +$157K 0.27% 83
2019
Q2
$1.12M Buy
+9,776
New +$1.12M 0.27% 78
2019
Q1
Sell
-6,897
Closed -$936K 167
2018
Q4
$936K Buy
6,897
+725
+12% +$98.4K 0.28% 75
2018
Q3
$1.69M Sell
6,172
-476
-7% -$131K 0.43% 45
2018
Q2
$1.38M Sell
6,648
-126
-2% -$26.1K 0.36% 49
2018
Q1
$1.12M Sell
6,774
-103
-1% -$17K 0.3% 56
2017
Q4
$942K Sell
6,877
-21
-0.3% -$2.88K 0.26% 69
2017
Q3
$939K Buy
6,898
+21
+0.3% +$2.86K 0.26% 71
2017
Q2
$835K Sell
6,877
-51
-0.7% -$6.19K 0.24% 76
2017
Q1
$733K Buy
6,928
+153
+2% +$16.2K 0.22% 85
2016
Q4
$688K Sell
6,775
-32
-0.5% -$3.25K 0.21% 93
2016
Q3
$651K Buy
6,807
+61
+0.9% +$5.83K 0.21% 85
2016
Q2
$805K Sell
6,746
-250
-4% -$29.8K 0.26% 59
2016
Q1
$749K Buy
6,996
+11
+0.2% +$1.18K 0.25% 64
2015
Q4
$757K Buy
6,985
+3,055
+78% +$331K 0.26% 65
2015
Q3
$337K Buy
3,930
+29
+0.7% +$2.49K 0.12% 109
2015
Q2
$394K Buy
+3,901
New +$394K 0.13% 108